No abstract

No abstract

No abstract

No abstract

No abstract

5. Zaghloul MS, Boutrus R, El-Hossieny H, et al: A prospective, randomized, placebo-controlled trial of zoledronic acid in bony metastatic bladder cancer. Int J Clin Oncol 15:382-389, 2010 6. Morgan GJ, Davies FE, Gregory WM, et al: First-line treatment with zoledronic acid as compared with clodronic acid in multiple myeloma (MRC Myeloma IX): A randomised controlled trial. Lancet 376 :1989-1999, 2010 7. Liu P, Leong T, Quam L, et al: Activating mutations of N-and K-ras in multiple myeloma show different clinical associations:

No abstract

Low-Pt content (5%) carbon-supported Pt-NiTiO 2 nanotube electrocatalysts were prepared via a microwave-assisted polyol strategy. Physical and morphological properties of these electrocatalysts were characterized by X-ray diffraction (XRD), high resolution transmission electron microscope (HRTEM), and energy dispersive X-ray spectroscopy (EDX). Cyclic voltammetry and chronoamperometry studies clearly suggested that the Pt(5%)-Ni(10%)-TiO 2 nanotube (10%) supported by Vulcan XC-72 is better than the commercial 20% Pt/C electrocatalyst for methanol electro-oxidation in direct methanol fuel cells (DMFCs).